Esperion Therapeutics, Inc.
NASDAQ:ESPR
2.03 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2002 | 2001 | 2000 | 1999 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 82.248 | 124.775 | 208.892 | 304.962 | 166.13 | 36.973 | 34.468 | 38.165 | 77.336 | 85.038 | 56.537 | 6.512 | 1.571 | 40.499 | 70.286 | 70.228 | 5.904 |
Short Term Investments
| 0 | 42.086 | 50.441 | 0 | 34.651 | 99.05 | 165.731 | 173.418 | 134.925 | 20.803 | 3.525 | 0 | 0 | 4.354 | 0 | 0 | 0 |
Cash and Short Term Investments
| 82.248 | 124.775 | 208.892 | 304.962 | 166.13 | 36.973 | 34.468 | 38.165 | 77.336 | 85.038 | 60.062 | 6.512 | 1.571 | 44.853 | 70.286 | 70.228 | 5.904 |
Net Receivables
| 48.494 | 33.729 | 22.934 | 12.388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 65.623 | 35.201 | 34.394 | 16.136 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 4.7 | 9.866 | 62.752 | 24.798 | 10.933 | 6.609 | 3.725 | 1.994 | 2.133 | 0.926 | 0.557 | 0.627 | 0.293 | 0.41 | 1 | 1.112 | 0.139 |
Total Current Assets
| 201.065 | 246.683 | 328.972 | 345.896 | 211.714 | 142.632 | 203.924 | 213.577 | 214.394 | 106.767 | 60.62 | 7.138 | 1.864 | 45.263 | 71.286 | 71.34 | 6.043 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 4.675 | 1.2 | 2.562 | 7.306 | 2.677 | 0.52 | 0.435 | 0.674 | 0.807 | 0.78 | 0.081 | 0.12 | 0.252 | 3.001 | 3.313 | 2.503 | 1.956 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.108 | 3.108 | 0 | 0 |
Intangible Assets
| 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.054 | 0.054 | 0 | 0 | 3.5 | 0 |
Goodwill and Intangible Assets
| 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.056 | 0.054 | 0.054 | 3.108 | 3.108 | 3.5 | 0 |
Long Term Investments
| 0 | 42.086 | 50.441 | 0 | 34.651 | 99.293 | 239.151 | 204.324 | 215.24 | 56.544 | 17.538 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | -50.441 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| -0 | -42.086 | 50 | -7.362 | -34.651 | -99.05 | -165.731 | -173.418 | -134.925 | -20.803 | 0 | -0.174 | 0.01 | 0.035 | 0.633 | 0.534 | 0 |
Total Non-Current Assets
| 4.731 | 1.256 | 52.618 | 7.362 | 2.733 | 0.819 | 73.911 | 31.636 | 81.178 | 36.577 | 17.674 | 0.174 | 0.316 | 6.144 | 7.054 | 6.537 | 1.956 |
Total Assets
| 205.796 | 247.939 | 381.59 | 353.258 | 214.447 | 143.451 | 277.835 | 245.213 | 295.572 | 143.344 | 78.294 | 7.312 | 2.18 | 51.407 | 78.34 | 77.877 | 7.999 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 31.718 | 23.04 | 17.559 | 51.975 | 28.856 | 44.893 | 20.375 | 4.595 | 0.707 | 2.04 | 2.232 | 0.476 | 0.691 | 1.687 | 2.925 | 3.936 | 1.425 |
Short Term Debt
| 36.381 | 0.384 | 1.392 | 2.587 | 0.454 | 0 | 1.045 | 1.709 | 1.604 | 0.638 | 0 | 15.241 | 0 | 1.061 | 0.863 | 0.697 | 0.495 |
Tax Payables
| 0 | 0 | 0 | 0 | 0.037 | 0.044 | 0.038 | 0.04 | 0.037 | 0.107 | 0.095 | 0.013 | 0.003 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 25.402 | 3.507 | 5.683 | 1.662 | 2.152 | 0 | 0.038 | 0.04 | 0.037 | 0.107 | 0 | 1.191 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 62.723 | 65.377 | 48.718 | 37.845 | 34.618 | 19.44 | 11.686 | 9.245 | 3.277 | 2.706 | 1.971 | 0.265 | 0.648 | 2.185 | 2.572 | 2.526 | 0.98 |
Total Current Liabilities
| 156.224 | 92.308 | 73.352 | 94.069 | 66.08 | 64.333 | 33.144 | 15.589 | 5.625 | 5.491 | 4.202 | 17.173 | 1.339 | 4.933 | 6.36 | 7.159 | 2.9 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 501.546 | 260.564 | 258.804 | 182.821 | 1.109 | 0 | 0 | 1.022 | 2.688 | 4.299 | 0 | 7.529 | 6.897 | 7.731 | 5.482 | 3.027 | 2.284 |
Deferred Revenue Non-Current
| 0 | 0 | 0.634 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 3.02 | 218.845 | 245.744 | 172.502 | 127.308 | 0 | 0 | 0 | 0 | 0 | 0 | -7.529 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 504.566 | 479.409 | 505.182 | 355.323 | 128.417 | 0 | 0 | 1.022 | 2.688 | 4.299 | 0 | 7.529 | 6.897 | 7.731 | 5.482 | 3.027 | 2.284 |
Total Liabilities
| 660.79 | 571.717 | 578.534 | 449.392 | 194.497 | 64.333 | 33.144 | 16.611 | 8.313 | 9.79 | 4.202 | 24.702 | 8.237 | 12.664 | 11.842 | 10.186 | 5.184 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 78,293.86 | 23.975 | 23.975 | 0 | 0 | 0 | 0 |
Common Stock
| 0.118 | 0.075 | 0.061 | 0.026 | 0.027 | 0.027 | 0.026 | 0.023 | 0.023 | 0.02 | 0.015 | 0 | 0 | 0.029 | 0.029 | 0.026 | 0.002 |
Retained Earnings
| -1,549.284 | -1,340.036 | -1,106.377 | -838.817 | -695.266 | -598.101 | -396.291 | -229.2 | -154.222 | -104.438 | -68.063 | -41.975 | -30.233 | -94.046 | -65.32 | -40.389 | -12.813 |
Accumulated Other Comprehensive Income/Loss
| -0 | -0.002 | -0.031 | 0 | 0.023 | -0.319 | -0.845 | -0.172 | -0.482 | -0.059 | -0.003 | -1.166 | -1.037 | -3.69 | -2.415 | -1.256 | -0.472 |
Other Total Stockholders Equity
| 1,094.172 | -0.073 | -0.03 | -0.026 | -0.05 | 0.292 | 641.801 | 457.951 | 441.94 | 238.031 | -78,151.718 | 1.776 | 1.239 | 136.45 | 134.204 | 109.31 | 16.098 |
Total Shareholders Equity
| -454.994 | -1,340.036 | -1,106.377 | -838.817 | -695.266 | -598.101 | 244.691 | 228.602 | 287.259 | 133.554 | 74.091 | -17.39 | -6.057 | 38.743 | 66.498 | 67.691 | 2.815 |
Total Equity
| -454.994 | -1,340.036 | -1,106.377 | -838.817 | -695.266 | -598.101 | 244.691 | 228.602 | 287.259 | 133.554 | 74.091 | -17.39 | -6.057 | 38.743 | 66.498 | 67.691 | 2.815 |
Total Liabilities & Shareholders Equity
| 205.796 | -768.319 | -527.843 | -389.425 | -500.769 | -533.768 | 277.835 | 245.213 | 295.572 | 143.344 | 78.294 | 7.312 | 2.18 | 51.407 | 78.34 | 77.877 | 7.999 |